The United States Food and Drug Administration has alerted the medical community and its patients of a potentially serious over infusion problem associated with the “Key Bounce” infusion pump. The defective pump is said to infuse as much as ten times the intended amount in patients who use the product manufactured by Alaris Products. For more information on the Alaris SE Infusion Pump Recall click here…
Alaris SE "Key Bounce" Infusion Pumps Recalled
The United States Food and Drug Administration has alerted the medical community and its patients of a potentially serious over infusion problem associated with the “Key Bounce” infusion pump. The defective pump is said to infuse as much as ten times the intended amount in patients who use the produ
@large.jpg)

M. Brandon Smith
Brandon Smith is a partner at Childers, Schlueter & Smith (CSS) in Atlanta, Georgia. He represents individuals nationwide in pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
All articles
Tags:
Legal